Wednesday, August 26, 2026

Tech Earnings

5 articles

Nebius Group Jumps 15.72% as AI Infrastructure Earnings Prove Revenue Model

Nebius Group Jumps 15.72% as AI Infrastructure Earnings Prove Revenue Model

Nebius Group's Q1 2026 earnings triggered a 15.72% single-day stock gain, signaling a market shift in how investors value AI infrastructure companies. GPU cloud operators and AI factories are now being assessed on real, reportable revenue rather than speculative future cash flows. The sector faces re-rating from growth story to proven revenue model.

LM Salvado
Tech Companies Trade Revenue Growth for Margin Expansion as Profitability Push Takes Hold

Tech Companies Trade Revenue Growth for Margin Expansion as Profitability Push Takes Hold

10x Genomics increased gross margin from 68% to 72% while cutting operating expenses from $147.9M to $95.0M, despite revenue declining from $610.8M to $28M. The shift mirrors a broader tech sector trend as CrowdStrike, Marvell, Snowflake, and Okta prepare Q4 earnings that will test whether margin expansion can offset slowing revenue growth.

ViaNews Editorial Team (Markets)
Nvidia Q4 Earnings on Feb 25 Will Test $2 Trillion AI Hardware Thesis

Nvidia Q4 Earnings on Feb 25 Will Test $2 Trillion AI Hardware Thesis

Nvidia reports Q4 2025 earnings on February 25, a critical test for AI infrastructure demand that propelled the company past $2 trillion valuation. Analysts expect datacenter GPU revenue to show whether hyperscaler spending continues after Microsoft's Azure growth and Broadcom's 2025 rally signaled sustained demand. The report will set the tone for semiconductor stocks entering Q1 2026.

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com